1. Introduction {#sec1}
===============

Gender and race/ethnic disparities have been often reported in United States with women and minority groups receiving less cardiac catheterization (CATH), thrombolytic therapy, percutaneous coronary interventions (PCI), coronary artery bypass graft (CABG) surgery, aspirin (ASA), beta-blockers, angiotensin converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB), statins, and referral to cardiac rehabilitation than men and Whites. These disparities have been documented extensively in women and African-Americans \[[@B1]--[@B15]\] but a paucity of current information exists in Hispanics, who have been frequently underrepresented in the pertinent literature. In general, most of the information in Hispanics has either been obtained more than 10 years ago \[[@B8], [@B18]--[@B20]\] and/or from hospitals with a proportionally very limited Hispanic patient representation (not beyond 1--5% of the data base analyzed) \[[@B8], [@B19]--[@B21]\]. In health care the interaction of socioeconomic factors with the cultural characteristics of patients and providers has a universally recognized importance \[[@B23], [@B24]\]. The objective of the present study is to provide insights in this issue analyzing the experience of a hospital with a large Hispanic representation.

2. Methods {#sec2}
==========

Medical records of 607 consecutive patients admitted with a suspected acute myocardial infarction (AMI) between January 2004 and December 2006 to a southern California nonprofit community Hospital with on site tertiary level of cardiac care were reviewed.

Twenty-four percent of the registered nurses (RN) and technical staff, 32% of the admitting physicians to the medical floor and intensive care unit, 62% of the cardiologists, and 40% of the cardiac surgeons were Hispanics. Baseline information of age, gender, race/ethnicity, previously documented coronary heart disease (MI, previous coronary revascularization), cardiovascular risk factors (CVRF) (history of hypertension, diabetes, dyslipidemia, smoking, congestive heart failure, renal failure), and medical insurance were obtained from the medical records.

2.1. Definition of Variables {#sec2.1}
----------------------------

### 2.1.1. Race and Ethnicity {#sec2.1.1}

They are Self-reported by the patients or direct members of the family on admission. 463 patients (245 women) had Hispanic (287, 62%) or Non-Hispanic White (176, 38%) ethnicity and were the subjects of the study. Approximately 85% of patients classified as Hispanics reported a Mexican ancestry or origin.

2.2. CVRF {#sec2.2}
---------

Identified by data from the medical records provided by patients, family members, and/or previous admissions. History or evidence of use of medications for hypertension, diabetes, or lipid disorders was considered confirmatory of a risk factor. Smokers were considered those who were current smokers for the 12 months prior to their hospital admission. Creatinine values of 1.8 mg/% or greater, or hemodialysis, were considered indicative of renal failure.

Standard ER and inpatient diagnostic procedures (serial EKG, Troponin I, and CPK) according to the currently accepted diagnostic criteria were utilized to confirm an AM I \[[@B25]\]. Stress testing, CATH, and coronary revascularization procedures were performed as recommended by the consulting or attending cardiologist and patient\'s preference.

Referral to Cardiac Rehabilitation was provided to all in-patients with a confirmed AMI or patients subject to revascularization procedures, and included inpatient physical activities, dietary, and smoking cessation counseling.

Excluded were patients that presented to the ER with a cardiopulmonary arrest in progress, or those who were transferred to other facilities.

2.3. Outcomes Assessment {#sec2.3}
------------------------

The following outcomes were measured: hospital mortality, all AMI (Non ST segment elevation MI + STEMI), stress testing, cardiac catheterization (CATH), percutaneous coronary interventions (PCI), coronary bypass graft surgery (CABG), and use (in hospital and at discharge) of ASA, beta-blockers, statins/antilipidemics, ACEI)/ARB, and clopidogrel for patients with a confirmed AMI. A composite drug index was calculated averaging the proportion of in-hospital and discharge use of these medications. Very few patients (*N* = 12) were treated with thrombolytic therapy and were not included in the data analysis.

2.4. Medical Insurance Characteristics {#sec2.4}
--------------------------------------

Medical insurance was analyzed considering the following groups.

\(1\) Private insurance, including all types of primary or supplemental insurances not financed by the government or state (i.e., private fee-for-service insurance, Health Maintenance Organizations).

\(2\) Nonprivate insurance, composed of all primary government and/or state financed insurance. These corresponded to Medical, Medicare/Medical, Community Health Center for Medicare & Medicaid Services (patients without insurance at the time of admission but considered eligible for Medical, or Medicare-Medical) and patients with no insurance and not eligible for government or state financed insurance.

2.5. Statistical Analysis {#sec2.5}
-------------------------

Between group comparisons for all patients with confirmed MI (*n* = 387) were performed for the following pair wise comparisons:men versus womenHispanic versus non-Hispanic White.For the categorical variables 2 × 2 chi-square analysis was conducted. Besides the *P* value, for designated outcomes (death, CATH, PCI, CABG, and stress testing) the Odds Ratio (OR) and 95% confidence interval adjusted by multivariable logistic regression considering as predictors age, gender, Hispanic/non-Hispanic White ethnicity, CVRF, private/non private medical insurance were obtained. For the composite drug use index a Poisson regression was calculated for the same outcomes and predictors. For testing differences in proportions (specifically for the insurance analyses) a SPSS macro was downloaded that specifically furnishes tests of significance via the *z* test of difference in proportions \[[@B26]\].

3. Results {#sec3}
==========

3.1. Baseline Characteristics {#sec3.1}
-----------------------------

### 3.1.1. Men versus Women {#sec3.1.1}

No differences were observed between men and women with respect to age, history of diabetes, hypertension, and lipid disorders in patients with a confirmed AMI. Previous MI, smoking, and history of CHF were more frequent in men ([Table 1](#tab1){ref-type="table"}).

No differences were noted in the proportion of private or nonprivate insurance according to gender. However, women had more Medical (11.8 versus 6.0%, *P* = 0.025), Community Health insurance and other nonprivate insurance (8.6 versus 3.7%, *P* = 0.026) than men (data not shown in Tables).

### 3.1.2. Hispanics versus Non-Hispanic Whites {#sec3.1.2}

Hispanics were younger than non-Hispanic whites and had more diabetes but similar BMI, an other CVRF ([Table 1](#tab1){ref-type="table"}). In a subgroup analysis (data not included in Tables) Hispanic women reported less smoking than non-Hispanic White women (21.9% versus 37.5%, *P* = 0.026); no differences were found between their male counterparts (45.2 versus 37.1 respectively, *P* = 0.23).

Hispanics had more nonprivate (government and state financed insurance) than non-Hispanic whites (66.8% versus 43.0%, *P* \< 0.001) ([Table 1](#tab1){ref-type="table"}).

3.2. Outcomes {#sec3.2}
-------------

### 3.2.1. Men versus Women {#sec3.2.1}

Men had a higher proportion of confirmed AMI and STEMI and received more CATH, PCI and CABG than women, but had similar mortality. Women, on the other hand, had more stress testing than men in patients admitted with a suspected AMI ([Table 2](#tab2){ref-type="table"}). However, in patients with a confirmed AMI after multivariable logistic adjustment these gender differences disappear for cardiac catheterization and PCI but persisted for CABG (Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"}).

### 3.2.2. Hispanics versus Non-Hispanic Whites {#sec3.2.2}

After full adjustment for all predictors, Hispanics had similar mortality, CATH, PCI, CABG and composite drug use than non-Hispanic Whites. (Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"}).

### 3.2.3. Cardiovascular Risk Factors and Outcomes {#sec3.2.3}

After adjustment for all predictors, age and renal failure increased significantly mortality (Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"}), diabetics received more PCI and CABG, and in contrast, patients with renal failure had less CATH, PCI, and a reduced composite drug use (Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"}).

### 3.2.4. Medical Insurance and Outcomes {#sec3.2.4}

No apparent relationship was documented between the type of medical insurance and the proportion of patients that received CATH, PCI, CABG, stress testing and composite drug use (Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"}). Patients with private insurance showed a lower mortality after adjustment for all the predictors than those with non private insurance when an AMI was confirmed (OR 0.33, 95% CI 0.12--0.99, [Table 3](#tab3){ref-type="table"}). No differences in age and CVRF were noted according to insurance status (data not included in tables).

4. Discussion {#sec4}
=============

The key findings of our study, conducted in a facility with a large representation of Hispanic patients and providers may be summarized as follows: (1) no race/ethnic or gender disparities were found in AMI care, (2) use of diagnostic and therapeutic resources were consistent with current expected performance measures \[[@B3]\]. These results are in contrast with previous publications on this subject \[[@B8], [@B15], [@B19], [@B29], [@B30]\].

Although demographically different than many other facilities where Hispanics are admitted, the site of the study was similar in reflecting the usual care of AMI patients in United States. Our findings of higher rates of diabetes in Hispanics than in non-Hispanic whites and lower smoking prevalence in Hispanic women have been previously well documented \[[@B27], [@B28]\]. It was also not surprising the larger number of confirmed AMI in men after admission considering the higher proportion of cardiovascular risk factors they presented with, in comparison to women.

Two studies with large databases that required voluntary enrollment of hospitals for monitoring guidelines and performance measures (GWTG-CAD) \[[@B16]\] or were part of multicenter randomized management protocols (SYNERGY) showed no significant disparities of care in Hispanics. However, because of the characteristics of these studies their results likely do not reflect the reality of usual care in most US hospitals. A more recent publication noted higher AMI readmissions rates for Hispanics regardless of the hospital characteristics (Hispanic serving hospital were defined as those that cared for an average of 12.5% of Hispanic patients while 0.5% in the non-Hispanic serving hospital). A lower quality of care score for the Hispanic serving hospitals was noted, and these were in larger proportion for profit and teaching facilities compared to their counterparts \[[@B17]\].

In our study, Hispanics had significantly more nonprivate insurance (state or government subsidized medical insurances provided to low-income individuals or no insurance) than non-Hispanic whites, which are consistent with previous studies in minority groups in the USA \[[@B15], [@B20], [@B29], [@B30], [@B32]\]. Medical insurance, among other factors, has been considered a proxy for socio-economic status, and was suggested as a source of provider bias \[[@B32]--[@B34]\]. In contrast to previous published reports, differences in medical insurance showed no apparent influence in the use of invasive and revascularization procedures or drug therapy in our study \[[@B32], [@B33]\]. There were no differences in death rate between Hispanics and non-Hispanic whites, but a higher mortality was noted in patients with confirmed AMI who had nonprivate insurance after multivariable logistic adjustment. It is conceivable that socioeconomic determinants that were not measured in this study, such as education, income, and environmental characteristics could have been at play as it has been extensively reported in the lower socioeconomic strata \[[@B23], [@B24], [@B35], [@B36]\].

Multiple factors ranging from socioeconomic, patient and cultural characteristics, to provider bias and racial/ethnic stereotyping have been suggested to account for the reported disparities of care in women and minorities \[[@B8], [@B23], [@B32], [@B33]\]. Culturally competent health care systems have been proposed to improve disparities in care for minorities. Although there is published information suggesting their effectiveness in health care of minorities \[[@B37]--[@B40]\], there have been no studies regarding their impact in the quality of care and outcomes of Hispanics admitted with an AMI. Moreover, there is no current information focused on the quality of care received by Hispanic women presenting with an AMI.

Hispanics are a culturally and racially heterogeneous group with different degrees of acculturation to the U.S. main stream. Data from the US Census Bureau indicate that 47.9% of Hispanic patients admitted to hospitals speak only Spanish or English "less than very well", but not more than 7% of the civilian employed health care professionals (RN, physicians, technicians) of the U.S are Hispanic \[[@B41]\]. Although the current national US figures for hospital Hispanic health care professionals are unknown, that number is probably a reasonable approximation. Data from the Association of the American Medical Colleges indicates that 5.1% of the cardiologists graduated from USA medical schools were Hispanics in 2004 \[[@B42]\]. These figures are in striking contrast with the much larger proportion of Hispanic care providers involved in our study as illustrated in [Figure 1](#fig1){ref-type="fig"}. However, it is uncertain if acculturation and cultural competency indicators influenced these results because they were not directly evaluated in our study. It is also unclear if the services available at our site were determinant factors since the information published on this issue has been inconclusive \[[@B11], [@B15], [@B32], [@B43]\].

4.1. Limitations {#sec4.1}
----------------

First, a major limitation of this study is its small sample size and limited generalizability since it reflects the experience of a single hospital with a large proportion of Hispanic patients and providers. These characteristics different from most hospitals in the United States, may have minimized acculturation and access barriers for Hispanics and enhanced cultural competency of the site, factors that probably would have contributed to a larger impact on disparities. On the other hand, the site where the study was conducted is similar to many other facilities in United States since it was not enrolled in studies that could have influenced the management of patients, and therefore it is closer to the reality of usual care of many other hospitals. Second, the presence of cardiovascular risk factors was only determined by information provided by the patients and/or the family members, or by data from previous admissions. Finally, the door to balloon time for PCI procedures in patients presenting with STEMI was not measured, which is an important quality of care indicator in the management of AMI.

5. Conclusions {#sec5}
==============

No disparities in the quality of care or outcomes related to gender, race/ethnicity, or medical insurance characteristics between Hispanics and non-Hispanic Whites admitted with a suspected AMI to a facility with a large Hispanic representation of patients and providers were found. These results may reflect a combination of factors that include the widespread implementation of current guidelines of care in U.S., the sociocultural features of a hospital with a large Hispanic representation of patients and providers and the characteristics of the on site services. Future studies including a larger sample of hospitals with a substantial Hispanic representation from various United States regions along with the assessment of indicators of acculturation and cultural competency may add more insights on this issue.

Fundacion Araucaria Foundation, a San Diego private nonprofit organization provided financial support for this study.

CATH:

:   Cardiac catheterization

PCI:

:   percutaneous coronary intervention (angioplasty and/or stent)

CABG:

:   Coronary artery bypass graft

ACEI:

:   Angiotensin converting enzyme inhibitor

ARB:

:   Angiotensin receptor blocker

CVRF:

:   Cardiovascular risk factor

NHW:

:   White.

![Proportion of Hispanic patients, nurses/technicians and physicians from the hospital in this study and from the database published from other US facilities and sources.](CRP2013-975393.001){#fig1}

###### 

Baseline characteristics of patients admitted with acute myocardial infarction (AMI) according to gender and race ethnicity.

                          Men       Women      *P* value   Hispanics   Non-Hispanic whites   *P*-value                                 
  ----------------------- --------- ---------- ----------- ----------- --------------------- ----------- --------- --------- --------- -------------
  Total (*n* = 387)       212       54.8       175         45.2                              229         59.2      158       40.8       
  Age                     *68.25*   *14.983*   *67.72*     *13.124*    0.68                  *66.85*     *13.92*   *69.87*   *14.30*   **0.026**
  BMI (kg/m^2^)           *27.31*   *4.70*     *28.44*     *6.79*      0.043                 *28.14*     *7.38*    *28.74*   *11.05*   0.669
  Hx of diabetes          94        44.3       90          51.4        0.165                 123         53.7      61        38.6      **0.003**
  Hx hypertension         147       69.3       136         77.7        0.064                 173         75.5      110       69.6      0.196
  Hx of smoking           88        41.5       48          27.4        **0.004**             77          33.6      59        37.3      0.452
  Hx dyslipidemia         115       54.2       108         61.7        0.139                 135         59        88        55.7      0.524
  Hx of previous MI       73        34.4       42          24          **0.025**             74          32.3      41        25.9      0.178
  Hx coronary revasc.     48        22.5       35          20          0.529                 50          21.8      33        20.9      0.823
  Hx of renal failure     53        25.4       32          18.3        **0.112**             57          24.9      28        17.7      0.094
  Hx of CVA               29        13.7       20          11.4        0.58                  26          11.4      23        14.6      0.352
  Hx of CHF               80        37.7       50          28.6        **0.050**             75          32.8      55        34.8      0.673
  Private insurance       96        45.3       70          40          0.298                 76          33.2      90        57        **\<0.001**
  non-private insurance   116       54.7       105         60.0        0.112                 153         66.8      68        43.0      **\<0.001**

BMI: Body mass index; Hx: history; MI: myocardial infarction; Revasc.: revascularization; CVA: cerebrovascular accident; CHF: congestive heart failure.

###### 

Selected outcomes in patients admitted with a suspected (*n* = 463) and confirmed (*n* = 387) Acute Myocardial Infarction according to gender and race ethnicity.

                                  Men   Women   *P* value   Hispanics   Non-Hispanic whites   *P* value                        
  ------------------------------- ----- ------- ----------- ----------- --------------------- ----------- ------ ----- ------- -----------
  Suspected AMI (*n* = 463)                                                                                                     
   Death                          16    7.3     10          4.1         0.129                 15          5.2    11    6.3     0.22
   Confirmed AMI                  212   97.2    175         71.4        **\<0.001**           229         79.8   158   89.8    **0.005**
   Stress testing                 10    4.6     54          22          **\<0.001**           43          15.0   21    11.9    0.36
   CATH                           152   69.7    126         51.4        **\<0.001**           171         59.6   107   60.8    0.79
   PCI                            80    36.7    54          22          **\<0.001**           82          28.6   52    29.5    0.82
   CABG                           49    22.5    25          10.2        **\<0.001**           50          17.4   24    13.6    0.28
  Confirmed AMI (*n* = 387)                                                                                                     
   Death                          16    7.5     10          5.7         0.47                  15          6.6    11    7       0.87
    STEMI                         77    36.3    33          18.9        **\<0.001**           59          25.8   51    32.3    0.167
   CATH                           147   69.3    110         62.9        0.179                 154         67.2   103   65.2    0.67
   PCI                            78    36.8    52          29.7        0.142                 78          34.1   52    32.9    0.81
   CABG                           46    21.7    24          13.7        **0.042**             47          20.5   23    14.6    0.134
  ASA (Hosp)                      193   93.7    126         92.1        0.566                 185         93.0   136   93.2    0.95
  Beta blockers (Hosp)            182   88.3    119         85.6        0.46                  175         87.9   126   86.3    0.65
  ACEI/ARB (Hosp)                 130   63.1    91          65.5        0.65                  125         62.8   96    65.8    0.57
  Statins/Antilipidemics (Hosp)   154   75.5    104         74.8        0.89                  146         73.7   112   77.2    0.46
  Clopidogrel (Hosp)              108   52.4    71          51.1        0.81                  104         52.3   75    51.4    0.87
  ASA (DC)                        165   87.3    119         88.1        0.82                  165         88.7   119   86.2    0.50
  Beta Blockers (DC)              149   78.4    102         75.6        0.54                  148         79.1   103   74.6    0.34
  ACEI/ARB (DC)                   94    50      74          55.2        0.36                  95          51.6   73    52.9    0.82
  Statins/Antilipidemics (DC)     135   71.4    96          71.1        0.95                  135         72.6   96    69.6    0.55
  Clopidogrel (DC)                100   53.2    67          49.6        0.53                  95          51.1   72    52.6    0.79
  Composite medications index     104   75.96   150         76.00       0.96                  146         76.2   107   75.73   0.924

AMI: acute myocardial infarction; CATH: cardiac catheterization; PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft; STEMI: ST segment elevation myocardial infarction; ASA: aspirin; Hosp: prescribed on admission; ACEI/ARB: angiotensin converting enzyme inhibitor/Angiotensin receptor blocker; DC: prescribed at discharge.

###### 

Odds ratio for selected outcomes in Hispanic and non-Hispanic white patients with a confirmed AMI.

  Predictors                            Death                   Cardiac cath   PCI                     CABG                                                                      
  ------------------------------------- ----------------------- -------------- ----------------------- ------------- ----------------------- ----------- ----------------------- -----------
  Age                                   **1.04** (1.00, 1.09)   **0.037**      **0.97** (0.95, 0.99)   **\<0.001**   0.98 (0.97, 1.0)        0.059       0.99 (0.97, 1.01)       0.155
  Men versus women                      1.33 (0.55, 3.22)       0.53           1.39 (0.87, 2.21)       0.16          1.37 (0.87, 2.16)       0.19        1.77 (0.99, 3.16)       0.05
  Hisp. versus non-Hispanic Whites      0.84 (0.34, 2.07)       0.71           1.04 (0.64, 1.67)       0.88          1.02 (0.64,1.63)        0.92        1.56 (0.86, 2.83)       0.14
  Hx diabetes.                          0.79 (0.32, 1.93)       0.60           1.06 (0.66, 1.71)       0.81          **1.54** (0.97, 2.46)   **0.049**   **2.26** (1.26, 4.07)   **0.006**
  Hx hypertension.                      1.38 (0.44, 4.40)       0.58           1.22 (0.71, 2.11)       0.47          0.71 (0.43, 1.18)       0.191       0.69 (0.37, 1.28)       0.24
  Hx smoking                            0.71 (0.26, 1.96)       0.51           1.55 (0.94, 2.57)       0.087         1.38 (0.86, 2.20)       0.179       0.62 (1.99, 0.48)       1.11
  Renal failure                         **3.03**(1.25, 7.37)    **0.014**      **0.39** (0.22, 0.67)   **0.001**     **0.47** (0.26, 0.86)   **0.014**   0.72 (0.35, 1.47)       0.36
  Hx Prev. MI                           0.82 (0.29, 2.27)       0.70           0.81 (0.47, 1.40)       0.45          1.01 (0.60, 1.71)       0.96        1.43 (0.76, 2.70)       0.26
  Hx Prev. Revasc.                      1.66 (0.60, 4.63)       0.33           0.89 (0.49, 1.61)       0.69          1.22 (0.68, 2.17)       **0.51**    0.24 (0.09, 0.63)       **0.003**
  Private versus nonprivate insurance   0.35 (0.12, 0.99)       **0.049**      0.66 (0.41, 1.07)       0.093         0.81 (0.51, 1.30)       0.39        1.27 (0.71, 2.26)       0.42

AMI: acute myocardial infarction; CATH: cardiac catheterization; PCI: percutaneous coronary intervention; CABG: coronary artery by-pass graft; Hisp.: Hispanic; Hx: History; Prev. MI: previous myocardial infarction; Prev. Revasc.: Previous coronary revascularization (PCI and/or CABG). \*Outcomes adjusted for age, gender, race/ethnicity, history of diabetes, hypertension, smoking, renal failure, previous MI, and previous CABG/PCI.

###### 

Events rates (Poisson regression) in Hispanic and non-Hispanic patients with a confirmed AMI for a composite drug use by multivariable logistic regression of the listed predictors.

  Composite drug index                  (All AMI *n* = 387)   Event R.    95% CI            
  ------------------------------------- --------------------- ----------- ---------- ------ ------
  Age                                   −0.002                0.157       1.00       0.99   1.00
  Men versus women                      −0.022                0.66        0.98       0.89   1.07
  Hispanic/non-Hispanic white           0.010                 0.83        1.01       0.92   1.11
  Hx diabetes                           0.037                 0.044       1.04       0.95   1.14
  Hx hypertension                       0.063                 0.23        1.07       0.96   1.18
  Hx smoking                            −0.010                0.084       0.99       0.90   1.09
  Renal failure                         −0.173                **0.003**   **0.84**   0.75   0.94
  Hx previous MI                        −0.045                0.41        0.96       0.86   1.06
  Hx previous revascularization         0.106                 0.082       1.11       0.99   1.25
  Private versus nonprivate insurance   0.041                 0.38        1.04       0.95   1.14

AMI: acute myocardial infarction; Drug Index: proportion of in-hospital and discharge use of drugs (please see Methods for details); Hx: history; MI: myocardial infarction.
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